{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:24:11Z","timestamp":1787084651542,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["GR24073"],"award-info":[{"award-number":["GR24073"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014181","name":"Junta de Extremadura","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015720","name":"University of Extremadura","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinthera.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:18:45Z","timestamp":1786450725000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of Medication Adherence in a Real-World Pharmacogenomics-Integrated Spanish Primary Care Cohort"],"prefix":"10.1016","author":[{"given":"Levin","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ojalvo-Guiberteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Antonio","family":"Villatoro-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mata-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Est\u00e9vez-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Buitrago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Su\u00e1rez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Cobaleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Pe\u00f1as-Lled\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-7081","authenticated-orcid":false,"given":"Adri\u00e1n","family":"LLerena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.07.008_sbref0001","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"Sabat\u00e9","year":"2003"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13350","article-title":"Prevalence of and factors associated with primary medication non-adherence in chronic disease: a systematic review and meta-analysis","volume":"73","author":"Cheen","year":"2019","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044987","article-title":"Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis","volume":"11","author":"Foley","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0004","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/bmjqs-2017-007453","article-title":"Hospital admissions associated with medication non-adherence: a systematic review of prospective observational studies","volume":"27","author":"Mongkhon","year":"2018","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104178","article-title":"Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175\/PEARLS trial","volume":"9","author":"Safren","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0006","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/bcp.14075","article-title":"The association between medication non-adherence and adverse health outcomes in ageing populations: a systematic review and meta-analysis","volume":"85","author":"Walsh","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016982","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review","volume":"8","author":"Cutler","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0008","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/bcp.13215","article-title":"Initial medication non-adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients","volume":"83","author":"Aznar-Lou","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0009","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11096-024-01832-9","article-title":"Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study","volume":"47","author":"Insani","year":"2025","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4321\/S1886-36552012000400005","article-title":"Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey","volume":"10","author":"Thunander Sundbom","year":"2012","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0011","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.3390\/ijerph18084308","article-title":"Factors associated with non-adherence to drugs in patients with chronic diseases who go to pharmacies in Spain","volume":"18","author":"Llorca","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/eurpub\/ckx159","article-title":"Demographic trends and public health in Europe","volume":"27","author":"England","year":"2017","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0013","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4235\/agmr.23.0137","article-title":"Polypharmacy in older patients: a three-year longitudinal analysis in primary care settings of Arag\u00f3n, Spain","volume":"28","author":"Matovelle","year":"2024","journal-title":"Ann Geriatr Med Res"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0014","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12877-020-01580-1","article-title":"Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65\u2009years of age: a longitudinal study","volume":"20","author":"Vill\u00e9n","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0015","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/bcp.16113","article-title":"The prevalence of polypharmacy in older Europeans: a multi-national database study of general practitioner prescribing","volume":"90","author":"Bennie","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214240","article-title":"Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States","volume":"14","author":"Oktora","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0017","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","article-title":"Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis","volume":"22","author":"Delara","year":"2022","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahr.2025.100256","article-title":"Polypharmacy and deprescribing among geriatric patients","volume":"5","author":"Ngcobo","year":"2025","journal-title":"Aging Health Res"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0019","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0020","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cpt.2705","article-title":"PharmVar GeneFocus: SLCO1B1","volume":"113","author":"Ramsey","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.v66n0103","article-title":"The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation","volume":"66","author":"de Leon","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0022","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/cts.12787","article-title":"Associations of CYP2C9 and CYP2C19 pharmacogenetic variation with phenytoin-induced cutaneous adverse drug reactions","volume":"13","author":"Fohner","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0023","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0024","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1186\/s40064-016-2912-z","article-title":"Association between SLCO1B1 -521T>C and -388A>G polymorphisms and risk of statin-induced adverse drug reactions: a meta-analysis","volume":"5","author":"Jiang","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0025","doi-asserted-by":"crossref","first-page":"9156","DOI":"10.1038\/s41467-024-53556-z","article-title":"Socio-demographic and genetic risk factors for drug adherence and persistence across 5 common medication classes","volume":"15","author":"Cordioli","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1017\/neu.2025.11","article-title":"Influence of CYP2D6 phenotype on adherence, adverse effects, and attitudes in aripiprazole and risperidone users","volume":"37","author":"Hietala","year":"2025","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0027","article-title":"Pharmacogenes that demonstrate high association evidence according to CPIC, DPWG, and PharmGKB","volume":"9","author":"Alshabeeb","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0028","article-title":"Clinical implementation of pharmacogenetics and personalized drug prescription based on e-health: the MedeA initiative","volume":"35","author":"LLerena","year":"2020","journal-title":"Drug Metab Pers Ther"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0029","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12910","article-title":"Impact of pharmacogenomics on clinical outcomes for patients taking medications with gene-drug interactions in a randomized controlled trial","volume":"80","author":"Thase","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cpt.1838","article-title":"Pharmacogenomic-based decision support to predict adherence to medications","volume":"108","author":"Christian","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0031","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt.2350","article-title":"An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine","volume":"110","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0032","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ajh.2009.205","article-title":"Adherence to medication: the importance of research in primary care","volume":"23","author":"Prado","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0033","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12875-019-1019-3","article-title":"Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study","volume":"20","author":"Fernandez-Lazaro","year":"2019","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0034","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12877-023-04256-8","article-title":"What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis","volume":"23","author":"Radcliffe","year":"2023","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0036","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0037","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2144\/000112044","article-title":"Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use","volume":"39","author":"Dorado","year":"2005","journal-title":"Biotechniques"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0038","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/cpt.2557","article-title":"The clinical pharmacogenetics implementation consortium guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin-associated musculoskeletal symptoms","volume":"111","author":"Cooper-DeHoff","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0039","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cpt.597","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0041","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/EDE.0b013e3181caeb90","article-title":"To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health","volume":"21","author":"Hubbard","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0042","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Statist Soc B"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0043","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cger.2012.01.008","article-title":"Medication adherence to multidrug regimens","volume":"28","author":"Marcum","year":"2012","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0044","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jamda.2023.07.016","article-title":"Deprescribing interventions for older patients: a systematic review and meta-analysis","volume":"24","author":"Zhou","year":"2023","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13098-020-00567-7","article-title":"Predictors of poor adherence to antidiabetic therapy in patients with type 2 diabetes: a cross-sectional study insight from Ethiopia","volume":"12","author":"Demoz","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0046","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/eurjhf\/hfp142","article-title":"Adherence to medication according to sex and age in the CHARM programme","volume":"11","author":"Granger","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0047","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11096-021-01236-z","article-title":"Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis","volume":"43","author":"Mahmood","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0048","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-007-0373-6","article-title":"Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole","volume":"63","author":"Hendset","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0049","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehp157","article-title":"Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease","volume":"30","author":"Varenhorst","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fpsyt.2018.00002","article-title":"Pharmacoresistant severe mental health disorders in children and adolescents: functional abnormalities of cytochrome P450 2D6","volume":"9","author":"Th\u00fcmmler","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0051","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70317","article-title":"CYP2C19-guided voriconazole therapy: a precision medicine approach to mitigate adverse effects in Japanese patients","volume":"18","author":"Katada","year":"2025","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0052","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00228-025-03858-y","article-title":"Pharmacogenomics-guided treatment versus conventional treatment in patients with Schizophrenia: evaluation of medication adherence and switching rate","volume":"81","author":"Wang","year":"2025","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0053","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/jpm9030040","article-title":"Pharmacogenomic testing: clinical evidence and implementation challenges","volume":"9","author":"Hippman","year":"2019","journal-title":"J Pers Med"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0054","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3390\/genes14101841","article-title":"Implementation of pharmacogenetics in first-line care: evaluation of its use by general practitioners","volume":"14","author":"van der Drift","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004565","article-title":"Pharmacogenetics and adverse drug reports: insights from a United Kingdom national pharmacovigilance database","volume":"22","author":"Magavern","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0056","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.pec.2016.01.020","article-title":"Health literacy and adherence to medical treatment in chronic and acute illness: a meta-analysis","volume":"99","author":"Miller","year":"2016","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0057","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2147\/PPA.S169236","article-title":"Medication adherence in chronic illness: do beliefs about medications play a role?","volume":"12","author":"Lemay","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0058","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/pharmaceutics13071100","article-title":"Factors contributing to medication adherence in patients with a chronic condition: a scoping review of qualitative research","volume":"13","author":"Kvarnstr\u00f6m","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0059","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3390\/medicina61091569","article-title":"Proton pump inhibitors (PPIs)\u2014an evidence-based review of indications, efficacy, harms, and deprescribing","volume":"61","author":"Andrawes","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0060","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.2147\/PPA.S485307","article-title":"Improving proton-pump inhibitor adherence intervention between primary care and community pharmacies: a pre-post intervention study","volume":"18","author":"Puig-Molt\u00f3","year":"2024","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0061","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12328-011-0208-y","article-title":"Proton pump inhibitors: use, misuse and concerns about long-term therapy","volume":"4","author":"Rakesh","year":"2011","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.clinthera.2026.07.008_sbref0062","series-title":"Medical Genetics Summaries","article-title":"CYP2D6 overview: allele and phenotype frequencies. 2021","author":"Kane","year":"2012"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0063","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/tpj.2015.70","article-title":"Interethnic variation of CYP2C19 alleles, \u2018predicted\u2019 phenotypes and \u2018measured\u2019 metabolic phenotypes across world populations","volume":"16","author":"Fricke-Galindo","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0064","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/pharmaceutics18010041","article-title":"Pharmacogenomics of CYP2D6, CYP2C19, CYP2C9, and clinical determinants of fluoxetine-norfluoxetine pharmacokinetics in real-world clinical conditions","volume":"18","author":"de la Cruz","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0065","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1517\/17425255.2015.1111871","article-title":"Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes","volume":"11","author":"C\u00e9spedes-Garro","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0066","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1517\/17425255.2014.964204","article-title":"Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations","volume":"10","author":"LLerena","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0067","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1200\/JCO.19.01535","article-title":"CYP2D6 genotype predicts tamoxifen discontinuation and prognosis in patients with breast cancer","volume":"38","author":"He","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0068","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/mp.2012.91","article-title":"CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients","volume":"18","author":"Pe\u00f1as-Lled\u00f3","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0069","first-page":"217","article-title":"CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications","volume":"10","author":"St Sauver","year":"2017","journal-title":"Pharmacogenomics Pers Med"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/tpj.2014.42","article-title":"A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances","volume":"15","author":"Pe\u00f1as-Lled\u00f3","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0071","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41398-022-02140-4","article-title":"A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts","volume":"12","author":"Pe\u00f1as-Lled\u00f3","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0072","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/pgs.11.146","article-title":"CYP2D6 and the severity of suicide attempts","volume":"13","author":"Pe\u00f1as-Lled\u00f3","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.clinthera.2026.07.008_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113202","article-title":"Drug metabolic enzyme genotype-phenotype discrepancy: high phenoconversion rate in patients treated with antidepressants","volume":"152","author":"Gloor","year":"2022","journal-title":"Biomed Pharmacother"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T19:26:34Z","timestamp":1787081194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826002699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":73,"alternative-id":["S0149291826002699"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.07.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of Medication Adherence in a Real-World Pharmacogenomics-Integrated Spanish Primary Care Cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}